Y. Gong

发表

Safety and efficacy of INC280 in combination with gefitinib (gef) in patients with EGFR-mutated (mut), MET-positive NSCLC: A single-arm phase lb/ll study.

M. Ahn, Yi-long Wu, E. Felip, 2014 .

Radiotherapy plus camrelizumaband irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial.

Yuehua Wu, Yongshun Chen, Shasha Ruan, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

D-1553 (garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients with Non-Small Cell Lung Cancer: Phase I Study Results.

Yanqiu Zhao, N. Yang, Yiping Zhang, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.